
FDA clears Dexcom G7 15-Day continuous glucose monitor
On April 10, 2025, Dexcom announced it had received FDA clearance for its Dexcom G7 15-Day continuous glucose monitoring system for use in adults aged 18 and older. The system extends wear time to 15.5 days and reports a mean absolute relative difference …